These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 22369133)
21. Lack of sufficiently strong informative features limits the potential of gene expression analysis as predictive tool for many clinical classification problems. Hess KR; Wei C; Qi Y; Iwamoto T; Symmans WF; Pusztai L BMC Bioinformatics; 2011 Dec; 12():463. PubMed ID: 22132775 [TBL] [Abstract][Full Text] [Related]
22. Comparison of performance of one-color and two-color gene-expression analyses in predicting clinical endpoints of neuroblastoma patients. Oberthuer A; Juraeva D; Li L; Kahlert Y; Westermann F; Eils R; Berthold F; Shi L; Wolfinger RD; Fischer M; Brors B Pharmacogenomics J; 2010 Aug; 10(4):258-66. PubMed ID: 20676065 [TBL] [Abstract][Full Text] [Related]
23. Network based consensus gene signatures for biomarker discovery in breast cancer. Fröhlich H PLoS One; 2011; 6(10):e25364. PubMed ID: 22046239 [TBL] [Abstract][Full Text] [Related]
24. Improving the prediction of chemotherapeutic sensitivity of tumors in breast cancer via optimizing the selection of candidate genes. Jiang L; Huang L; Kuang Q; Zhang J; Li M; Wen Z; He L Comput Biol Chem; 2014 Apr; 49():71-8. PubMed ID: 24440656 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value. Lehmann BD; Ding Y; Viox DJ; Jiang M; Zheng Y; Liao W; Chen X; Xiang W; Yi Y BMC Cancer; 2015 Mar; 15():179. PubMed ID: 25886164 [TBL] [Abstract][Full Text] [Related]
26. Many accurate small-discriminatory feature subsets exist in microarray transcript data: biomarker discovery. Grate LR BMC Bioinformatics; 2005 Apr; 6():97. PubMed ID: 15826317 [TBL] [Abstract][Full Text] [Related]
27. Accurate molecular classification of cancer using simple rules. Wang X; Gotoh O BMC Med Genomics; 2009 Oct; 2():64. PubMed ID: 19874631 [TBL] [Abstract][Full Text] [Related]
28. Effects of sample size on robustness and prediction accuracy of a prognostic gene signature. Kim SY BMC Bioinformatics; 2009 May; 10():147. PubMed ID: 19445687 [TBL] [Abstract][Full Text] [Related]
29. A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data. Luo J; Schumacher M; Scherer A; Sanoudou D; Megherbi D; Davison T; Shi T; Tong W; Shi L; Hong H; Zhao C; Elloumi F; Shi W; Thomas R; Lin S; Tillinghast G; Liu G; Zhou Y; Herman D; Li Y; Deng Y; Fang H; Bushel P; Woods M; Zhang J Pharmacogenomics J; 2010 Aug; 10(4):278-91. PubMed ID: 20676067 [TBL] [Abstract][Full Text] [Related]
30. Significant random signatures reveals new biomarker for breast cancer. Saberi Ansar E; Eslahchii C; Rahimi M; Geranpayeh L; Ebrahimi M; Aghdam R; Kerdivel G BMC Med Genomics; 2019 Nov; 12(1):160. PubMed ID: 31703592 [TBL] [Abstract][Full Text] [Related]
31. Prediction of early breast cancer patient survival using ensembles of hypoxia signatures. Gong IY; Fox NS; Huang V; Boutros PC PLoS One; 2018; 13(9):e0204123. PubMed ID: 30216362 [TBL] [Abstract][Full Text] [Related]
32. Identifying cancer biomarkers by network-constrained support vector machines. Chen L; Xuan J; Riggins RB; Clarke R; Wang Y BMC Syst Biol; 2011 Oct; 5():161. PubMed ID: 21992556 [TBL] [Abstract][Full Text] [Related]
33. A simple but highly effective approach to evaluate the prognostic performance of gene expression signatures. Starmans MH; Fung G; Steck H; Wouters BG; Lambin P PLoS One; 2011; 6(12):e28320. PubMed ID: 22163293 [TBL] [Abstract][Full Text] [Related]
34. A resampling-based meta-analysis for detection of differential gene expression in breast cancer. Gur-Dedeoglu B; Konu O; Kir S; Ozturk AR; Bozkurt B; Ergul G; Yulug IG BMC Cancer; 2008 Dec; 8():396. PubMed ID: 19116033 [TBL] [Abstract][Full Text] [Related]
35. Microarray based diagnosis profits from better documentation of gene expression signatures. Kostka D; Spang R PLoS Comput Biol; 2008 Feb; 4(2):e22. PubMed ID: 18282081 [TBL] [Abstract][Full Text] [Related]
36. Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures. Karn T; Pusztai L; Holtrich U; Iwamoto T; Shiang CY; Schmidt M; Müller V; Solbach C; Gaetje R; Hanker L; Ahr A; Liedtke C; Ruckhäberle E; Kaufmann M; Rody A PLoS One; 2011; 6(12):e28403. PubMed ID: 22220191 [TBL] [Abstract][Full Text] [Related]
37. DNA microarray-based ecotoxicological biomarker discovery in a small fish model species. Wang RL; Bencic D; Biales A; Lattier D; Kostich M; Villeneuve D; Ankley GT; Lazorchak J; Toth G Environ Toxicol Chem; 2008 Mar; 27(3):664-75. PubMed ID: 17990946 [TBL] [Abstract][Full Text] [Related]
38. Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsampling. Lee S; Rahnenführer J; Lang M; De Preter K; Mestdagh P; Koster J; Versteeg R; Stallings RL; Varesio L; Asgharzadeh S; Schulte JH; Fielitz K; Schwermer M; Morik K; Schramm A PLoS One; 2014; 9(10):e108818. PubMed ID: 25295525 [TBL] [Abstract][Full Text] [Related]